Skip to Main content Skip to Navigation
Patents

Process for enantiomeric separation of racemic dihydro-1,3,5 triazines via preferential crystallization

Matthias Helmreich Claus-Peter Niesert Daniel Cravo Gérard Coquerel 1 Guillaume Levilain 1 Saoussen Wacharine-Antar Pascal Cardinaël 1 
1 SMS - Sciences et Méthodes Séparatives
Abstract : A new process for the enantiomeric separation of racemic 3,6-dihydro-1,3,5-triazine derivatives for the treatment of disorders associated with insulin-resistance syndrome, by preferential crystallization.
Document type :
Patents
Complete list of metadata
https://hal-normandie-univ.archives-ouvertes.fr/hal-01949529
Contributor : Aurélien Lemercier Connect in order to contact the contributor
Submitted on : Monday, December 10, 2018 - 11:06:02 AM
Last modification on : Wednesday, March 9, 2022 - 3:56:04 PM

Identifiers

  • HAL Id : hal-01949529, version 1

Collections

COMUE-NORMANDIE | UNIROUEN | LABO-SMS

Citation

Matthias Helmreich, Claus-Peter Niesert, Daniel Cravo, Gérard Coquerel, Guillaume Levilain, et al.. Process for enantiomeric separation of racemic dihydro-1,3,5 triazines via preferential crystallization. France, Patent n° : EP2411375A1. 2009. ⟨hal-01949529⟩

Export

BibTeX TEI DC DCterms EndNote Datacite

Share

Metrics

Record views

10